1. Wang, Yaofeng, Wang, Gengqiao, Hu, Shaobo, Ke, Wenbo, Song, Zifang. 2023. FARSB Facilitates Hepatocellular Carcinoma Progression by Activating the mTORC1 Signaling Pathway. In International journal of molecular sciences, 24, . doi:10.3390/ijms242316709. https://pubmed.ncbi.nlm.nih.gov/38069034/
2. Guo, Ruolan, Chen, Yuanying, Hu, Xuyun, Li, Yuchuan, Hao, Chanjuan. 2023. Phenylalanyl-tRNA synthetase deficiency caused by biallelic variants in FARSA gene and literature review. In BMC medical genomics, 16, 245. doi:10.1186/s12920-023-01662-0. https://pubmed.ncbi.nlm.nih.gov/37833669/
3. Zadjali, Fahad, Al-Yahyaee, Aida, Al-Nabhani, Maryam, Raniga, Sameer, Al-Maawali, Almundher. 2018. Homozygosity for FARSB mutation leads to Phe-tRNA synthetase-related disease of growth restriction, brain calcification, and interstitial lung disease. In Human mutation, 39, 1355-1359. doi:10.1002/humu.23595. https://pubmed.ncbi.nlm.nih.gov/30014610/
4. Zhen, Jing, Pan, Jingying, Zhou, Xuanrui, Liu, Yue, Guo, Liangyun. 2023. FARSB serves as a novel hypomethylated and immune cell infiltration related prognostic biomarker in hepatocellular carcinoma. In Aging, 15, 2937-2969. doi:10.18632/aging.204619. https://pubmed.ncbi.nlm.nih.gov/37074800/
5. Zhang, Ziran, Tan, Jiale, Yu, Zihang, Wu, Dehua, Bai, Xue. . [FARSB stratifies prognosis and cold tumor microenvironment across different cancer types: an integrated single cell and bulk RNA sequencing analysis]. In Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 43, 667-679. doi:10.12122/j.issn.1673-4254.2023.05.01. https://pubmed.ncbi.nlm.nih.gov/37313807/
6. Karimzadeh, Parvaneh, Rezakhani, Sepideh, Miryounesi, Mohammad, Alijanpour, Sahar. 2022. Neurodegenerative disorder and diffuse brain calcifications due to FARSB mutation in two siblings. In Clinical case reports, 10, e6195. doi:10.1002/ccr3.6195. https://pubmed.ncbi.nlm.nih.gov/35937029/
智鼠故事 
